Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Matuszewski Jason, holds the title of Chief Executive Officer at BioStem Technologies, Inc..
On 2026-11-17, the insider transacted 14,300 shares.The shares were transacted at a weighted average price of $1.00 per share, resulting in a total market-relevant value of $14K.
Matuszewski Jason (Chief Executive Officer) sold $14K of $BSEM
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.